1-7 of 7
Vikram Shetty
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Budget impact of fixed duration acalabrutinib in combination with venetoclax in previously untreated chronic lymphocytic leukemia patients in the United States

Free
Farrukh Awan, Nadine Zawadzki, Anna Teschemaker, Kathy Wojtas, David Satre, Vikram Shetty, Dipen Patel, Fady Fam, Ryan Crowley, Jason Shafrin
Journal: Blood
Blood (2025) 146 (Supplement 1): 2627.
https://doi.org/10.1182/blood-2025-2627
Published: 2025
Journal Articles

Real-world incidence of treatment-emergent cardiovascular events among chronic lymphocytic leukemia/small lymphocytic lymphoma patients receiving acalabrutinib or zanubrutinib monotherapy

Free
Jing-Zhou Hou, Rushir Choksi, Anna Rui, Vikram Shetty, Anna Teschemaker, Kathy Wojtas, Steven Champaloux, Dipen Patel, Doug Kanovsky, Jeffrey Scott, Aliakbar Dadla, Daniel Allendorf
Journal: Blood
Blood (2025) 146 (Supplement 1): 4506.
https://doi.org/10.1182/blood-2025-4506
Published: 2025
Journal Articles

Use and outcomes following blinatumomab rechallenge in adolescents and young adults (AYA) and adults with B-cell acute lymphoblastic leukemia (B-ALL)

Free
Michaela Liedtke, Nikesh Shah, Jessica Leonard, Anthony Proli, Yazan Barqawi, Hui-Han Chen, Alan Yong, Vikram Shetty, Elias Jabbour, Mark Geyer
Journal: Blood
Blood (2025) 146 (Supplement 1): 1555.
https://doi.org/10.1182/blood-2025-1555
Published: 2025
Journal Articles

A Real-World Comparative Analysis of Hypertension and Time to Treatment Failure with Acalabrutinib Vs Ibrutinib in Treatment-Naïve Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Free
Daniel A. Ermann, George Dranitsaris, Sibel Blau, Aaron Peevyhouse, Heather Neuhalfen, Alan SM Yong, Tina K. Wahlstrom, Samantha L. Thompson, Anna Teschemaker, Vikram Shetty, Mayur S. Narkhede
Journal: Blood
Blood (2024) 144 (Supplement 1): 6367.
https://doi.org/10.1182/blood-2024-210396
Published: 2024
Journal Articles

Mutations in the Bruton Tyrosine Kinase (BTK) Gene in Patients with Chronic Lymphocytic Leukemia (CLL) Receiving BTK Inhibitors (BTKis)

Free
Alan P Skarbnik, Alexey V. Danilov, Marc Hoffmann, Farrukh T. Awan, Frank Scarpa, Caryn Davies, Todd Oakland, Marina Kovach, Jenna Lilyquist, Veerendra Munugalavadla, Alan SM Yong, Vikram Shetty, John N. Allan, Jennifer A. Woyach
Journal: Blood
Blood (2024) 144 (Supplement 1): 4623.
https://doi.org/10.1182/blood-2024-209590
Published: 2024
Journal Articles

Cost-Offset Analysis Performed Utilizing Covalent Bruton's Tyrosine Kinase Inhibitors Safety Profiles Among Medicare Patients with Chronic Lymphocytic Leukemia

Free
Adam S Kittai, Dipen A. Patel, Jason Shafrin, Nadine Zawadzki, Vikram Shetty, Khounish Sharma, Yazan K. Barqawi, Joanna M. Rhodes
Journal: Blood
Blood (2024) 144 (Supplement 1): 5031.
https://doi.org/10.1182/blood-2024-201039
Published: 2024
Journal Articles

A Matching-Adjusted Indirect Comparison of Acalabrutinib with and without Obinutuzumab Versus Zanubrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia

Free
John N. Allan, Adam S Kittai, Dan James, Helen Ridge, Miguel Miranda, Alan Yong, Fady Fam, Jack Roos, Vikram Shetty, Matthew S. Davids, Alan Skarbnik
Journal: Blood
Blood (2023) 142 (Supplement 1): 6563.
https://doi.org/10.1182/blood-2023-178698
Published: 2023